Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept.
Peyrode C, Weber V, Voissière A, Maisonial-Besset A, Vidal A, Auzeloux P, Gaumet V, Borel M, Dauplat MM, Quintana M, Degoul F, Rédini F, Chezal JM, Miot-Noirault E.
Peyrode C, et al. Among authors: weber v.
Mol Cancer Ther. 2016 Nov;15(11):2575-2585. doi: 10.1158/1535-7163.MCT-16-0003. Epub 2016 Aug 29.
Mol Cancer Ther. 2016.
PMID: 27573424